PATENT CLAIM ANALYSIS

Application Number: 16066574
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "234500"]

Abstract:
A novel class of fluorinated derivatives of Formula (I) have been prepared and found to be useful in the treatment of cancers and other EGFR related disorders.

Claim (Index 28):
A compound of  claim 1  that is: or a pharmaceutically acceptable salt and/or solvate thereof, or or a pharmaceutically acceptable salt and/or solvate thereof.

Metadata:
- Claim Count in Document: 25.0
- Percentile: 94.0
- Lexical Diversity: 1.11111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14466896', '15359370', '14234514', '14002983', '14399510']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7819920737689141
- 35 USC 102 Novelty (BERT): 0.5145634539929755
- Combined Prediction Score: 0.7552492117913203
- Mean Citation Score: 272.126818
- Max Citation Score: 283.61575
- Similarity Product: 210.7718496218621

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test